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Background: Purpose of our study was to identificate independent predictors of non-response (NR) of pulmonary artery hypertension (PAH) pts’ to 
long-term sildenafil therapy (fatal outcome).
methods: Our prospective observational study included 61 PAH pts’ (31 -idiopathic PAH, 30 - Eisenmenger’s syndrome) NYHA II-III aged 32,3±3,7 
years, 72,1% - female, with mean pulmonary artery pressure 104±10 mm Hg, treated with warfarin but sildenafil naïve. At baseline, before its 
prescription 50 mg pd, and at 6 months, 6 Minute Walk Test (6MWT), ECHO-CG and plasma levels of endotheline-1 (ET-1), von Willebrand factor 
(WF) were assessed with ELISA. In 21,4±3,3 months pts’ were retrospectively divided into responders (alive) and NR (who died from cardiovascular 
cause). For independent NR predictors’ identification 27 factors (demographic, clinical, ECHO-CG, 6MWT, ET-1 and WF) were assessed with stepwise 
discriminate analysis procedure.
Results: Baseline ET-1 in responders (n=45) vs. NR (n=16) was 1, 82 ± 0,04 vs. 2,09 ± 0,12 fmol/ml (p<0,05). NR was associated with baseline 
plasma ET-1 ≥ 2,0 fmol/ml (x1), its lowering by 6 months ≤ 0,5 fmol/ml (x2), symptoms for ≥ 8 years (x3), syncope episodes (x4), 6MWT increase 
≥ 10% by 6 months (x5). Their presence was assessed by “1” and absence - by “0”. Linear discriminate functions equations Y1 and Y2 had following 
appearance: Y1=-4,73917+5,54821*x1+3,15810*x2+6,7135*x3+4,63954*x4+5,11707*x5 Y2=-0,22306+0,80601*x1+1,14207*x2+0,91234*
x3+0,75671*x4+0.72280x*5. If Y1>Y2, probability of NR associated with fatal outcome was 86,7%. If x2-5 were “0” or unknown, and x1=1, Y1>Y2 
(eg NR risk -86,7%).
conclusions: Baseline plasma ET-1≥ 2,0 fmol/ml is the most significant independent predictor of NR to long-term 50 mg pd, sildenafil therapy in 
PAH patients (probability of cardiovascular death - 86,7%). Others are symptoms ≥ 8 years, syncope episodes, suboptimal ET-1 and 6MWT changes 
by 6 months.
